These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38077485)

  • 21. Radiomics-based prediction of nonalcoholic fatty liver disease following pancreatoduodenectomy.
    Fujii T; Iizawa Y; Kobayashi T; Hayasaki A; Ito T; Murata Y; Tanemura A; Ichikawa Y; Kuriyama N; Kishiwada M; Sakuma H; Mizuno S
    Surg Today; 2024 Aug; 54(8):953-963. PubMed ID: 38581555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From pixels to prognosis: unveiling radiomics models with SHAP and LIME for enhanced interpretability.
    Raptis S; Ilioudis C; Theodorou K
    Biomed Phys Eng Express; 2024 Mar; 10(3):. PubMed ID: 38498925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography.
    Taibbi A; Petta S; Matranga D; Caruana G; Cannella R; Busè G; Marco VD; Midiri M; Bartolotta TV
    Ultrasonography; 2021 Jul; 40(3):407-416. PubMed ID: 33561928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Wattacheril JJ; Abdelmalek MF; Lim JK; Sanyal AJ
    Gastroenterology; 2023 Oct; 165(4):1080-1088. PubMed ID: 37542503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort.
    De A; Keisham A; Mishra S; Mehta M; Verma N; Premkumar M; Taneja S; Das A; Singh V; Duseja A
    J Clin Exp Hepatol; 2022; 12(2):440-447. PubMed ID: 35535068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal
    Zuo Y; Liu Q; Li N; Li P; Zhang J; Song S
    Front Oncol; 2023; 13():1173355. PubMed ID: 37223682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpretable machine learning for predicting 28-day all-cause in-hospital mortality for hypertensive ischemic or hemorrhagic stroke patients in the ICU: a multi-center retrospective cohort study with internal and external cross-validation.
    Huang J; Chen H; Deng J; Liu X; Shu T; Yin C; Duan M; Fu L; Wang K; Zeng S
    Front Neurol; 2023; 14():1185447. PubMed ID: 37614971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease.
    Alam MS; Kamrul-Hasan ABM; Kalam ST; Rahman SMM; Hoque MI; Islam MB; Paul AK
    Diabetes Metab Syndr Obes; 2021; 14():3089-3096. PubMed ID: 34262313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.
    Wei Q; Chen Z; Tang Y; Chen W; Zhong L; Mao L; Hu S; Wu Y; Deng K; Yang W; Liu X
    Eur Radiol; 2023 Mar; 33(3):1906-1917. PubMed ID: 36355199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Imajo K; Honda Y; Kobayashi T; Nagai K; Ozaki A; Iwaki M; Kessoku T; Ogawa Y; Takahashi H; Saigusa Y; Yoneda M; Kirikoshi H; Utsunomiya D; Aishima S; Saito S; Nakajima A
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):908-917.e11. PubMed ID: 33340780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A radiomics method based on MR FS-T2WI sequence for diagnosing of autosomal dominant polycystic kidney disease progression.
    Cong L; Hua QQ; Huang ZQ; Ma QL; Wang XM; Huang CC; Xu JX; Ma T
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5769-5780. PubMed ID: 34604968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer.
    Moro F; Albanese M; Boldrini L; Chiappa V; Lenkowicz J; Bertolina F; Mascilini F; Moroni R; Gambacorta MA; Raspagliesi F; Scambia G; Testa AC; Fanfani F
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):256-268. PubMed ID: 34714568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease.
    Mendoza YP; Rodrigues SG; Delgado MG; Murgia G; Lange NF; Schropp J; Montani M; Dufour JF; Berzigotti A
    Liver Int; 2022 Jan; 42(1):102-111. PubMed ID: 34821035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease.
    Karagiannakis DS; Markakis G; Lakiotaki D; Cholongitas E; Vlachogiannakos J; Papatheodoridis G
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):961-966. PubMed ID: 35913779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine learning-based multiparametric magnetic resonance imaging radiomics model for distinguishing central neurocytoma from glioma of lateral ventricle.
    Mo H; Liang W; Huang Z; Li X; Xiao X; Liu H; He J; Xu Y; Wu Y
    Eur Radiol; 2023 Jun; 33(6):4259-4269. PubMed ID: 36547672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study.
    Shaheen AA; Riazi K; Medellin A; Bhayana D; Kaplan GG; Jiang J; Park R; Schaufert W; Burak KW; Sargious M; Swain MG
    CMAJ Open; 2020; 8(2):E370-E376. PubMed ID: 32414883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining Hepatic and Splenic CT Radiomic Features Improves Radiomic Analysis Performance for Liver Fibrosis Staging.
    Yin Y; Yakar D; Dierckx RAJO; Mouridsen KB; Kwee TC; de Haas RJ
    Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204639
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease.
    Sharpton SR; Tamaki N; Bettencourt R; Madamba E; Jung J; Liu A; Behling C; Valasek MA; Loomba R
    Therap Adv Gastroenterol; 2021; 14():17562848211050436. PubMed ID: 34646360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.